Measurement of pancreatic amylase in macroamylasaemic sera
In a recent paper,' Van Deun e t al. describe their experience with macroarnylasaemic samples in an immunoinhibition assay for pancreatic amylase. In this assay. two monoclonal antibodies were used to inhibit salivary amylase. For three of five macroamylasaemic sera assayed with this procedure, high values were obtained for the proportion of pancreatic amylase (67%. 80% and 89% of total arnylasc), thus 'falscly indicating pancreatic involvement'. The authors concluded that the inhibiting antibodies may have been unable to bind salivary amylase molecules that were part of a macroamylase complex. The experience described by Van Deun et al. is similar to that described by Rosenblum' using an antipancreatic monoclonal antibody.
We have had a different experience with macroamylases whcn sera arc assayed by a (monoclonal) immunoprecipitation method for pancreatic a m y l a~e .~ In this method, a (different) antisalivary monoclonal antibody removes salivary amylase(s). As shown in Fig. 1 monoclonal antibody was able to recognize and bind to the relevant epitope of salivary amylase in most of the macroamylase complexes. It seems that the interference of macroamylases in assays for pancreatic amylase is a method-dependent error. We would not be surprised to find specific macroamylases are recognized by either assay but not by the other. Microalbuminuria in diabetes mellitus I read with interest the excellent review by Rowe rt al. ' but would like to take issue with their recommendation that the concentration of albumin alone in an early morning or random urine specimen should not be used when screening for microalbuminuria in diabetes mellitus.
My colleagues and I have studied the ability of an albumin concentration > 17mg/L and an albumin : creatinine ratio > 3.0 mg/mmol in first morning urine specimens to predict an overnight albumin excretion rate (AER) > 30 mglmin.' In 261 samples from unselected insulin-dependent and non-insulin-dependent diabetics, the con-centration alone gave a sensitivity of 96.8% and a specificity of 90.9%. cornparcd with the ratio which gave a sensitivity of 96.8% and a specificity of 93.9%. In our study both the ratio and concentration alone missed one of 3 I specimens with high AER.
While there may be a theoretical argument that the dependence of albumin concentration on urine Row rate could result in the misclassification of patients if the conccntration alone is used as a screening test. this was not seen in our study. Further, the analysis of creatinine adds a n extra source of analytical variation as well as increasing the cost of the procedure.
I am satisfied that the albumin concentration of an early morning urine specimen can be used as a screening test for microalbuminuria in diabetes rnellitus, providing that positive samples are followed up with a timed overnight or 74 h collection.
